KIMBERLY MIZACK: Open Payments
NPI 1639251762 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,871 in 53 payments from 20 companies in 2025. Trend: 2023 $188 · 2024 $549 · 2025 $1,871
Food & beverage: $1,672Education: $199
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $272 |
| Boston Scientific Corporation | 2 | $269 |
| Teva Pharmaceuticals USA, Inc. | 6 | $256 |
| ABBVIE INC. | 8 | $245 |
| ARGENX US, INC. | 6 | $143 |
| UCB, Inc. | 4 | $113 |
| Biogen, Inc. | 3 | $86 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| Axsome Therapeutics, Inc. | 2 | $64 |
| ANI Pharmaceuticals, Inc. | 2 | $63 |
Products named: LUX-Dx Insertable Cardiac Monitor, KISUNLA, QULIPTA, Rystiggo, TYSABRI, KESIMPTA, VYVGART, VYVGART HYTRULO.
Industry payments across VA — which companies pay providers there.
